Mindfulness for Motor and Nonmotor Dysfunctions in Parkinson's Disease

Nadeeka N W Dissanayaka, Farah Idu Jion, Nancy A Pachana, John D O'Sullivan, Rodney Marsh, Gerard J Byrne, Paul Harnett, Nadeeka N W Dissanayaka, Farah Idu Jion, Nancy A Pachana, John D O'Sullivan, Rodney Marsh, Gerard J Byrne, Paul Harnett

Abstract

Background. Motor and nonmotor symptoms negatively influence Parkinson's disease (PD) patients' quality of life. Mindfulness interventions have been a recent focus in PD. The present study explores effectiveness of a manualized group mindfulness intervention tailored for PD in improving both motor and neuropsychiatric deficits in PD. Methods. Fourteen PD patients completed an 8-week mindfulness intervention that included 6 sessions. The Five Facet Mindfulness Questionnaire (FFMQ), Geriatric Anxiety Inventory, Hamilton Depression Rating Scale, PD Cognitive Rating Scale, Unified PD Rating Scale, PD Quality of Life Questionnaire, and Outcome Questionnaire (OQ-45) were administered before and after the intervention. Participants also completed the FFMQ-15 at each session. Gains at postassessment and at 6-month follow-up were compared to baseline using paired t-tests and Wilcoxon nonparametric tests. Results. A significant increase in FFMQ-Observe subscale, a reduction in anxiety, depression, and OQ-45 symptom distress, an increase in PDCRS-Subcortical scores, and an improvement in postural instability, gait, and rigidity motor symptoms were observed at postassessment. Gains for the PDCRS were sustained at follow-up. Conclusion. The mindfulness intervention tailored for PD is associated with reduced anxiety and depression and improved cognitive and motor functioning. A randomised controlled trial using a large sample of PD patients is warranted.

Figures

Figure 1
Figure 1
A summary of the mindfulness intervention.

References

    1. Dissanayaka N. N. W., Sellbach A., Matheson S., et al. Anxiety disorders in Parkinson's disease: prevalence and risk factors. Movement Disorders. 2010;25(7):838–845. doi: 10.1002/mds.22833.
    1. Dissanayaka N. N. W., Sellbach A., Silburn P. A., O'Sullivan J. D., Marsh R., Mellick G. D. Factors associated with depression in Parkinson's disease. Journal of Affective Disorders. 2011;132(1-2):82–88. doi: 10.1016/j.jad.2011.01.021.
    1. Weintraub D., Burn D. J. Parkinson's disease: the quintessential neuropsychiatric disorder. Movement Disorders. 2011;26(6):1022–1031. doi: 10.1002/mds.23664.
    1. Dissanayaka N. N. N. W., White E., O'Sullivan J. D., Marsh R., Pachana N. A., Byrne G. J. The clinical spectrum of anxiety in Parkinson's disease. Movement Disorders. 2014;29(8):967–975. doi: 10.1002/mds.25937.
    1. Aarsland D., Andersen K., Larsen J. P., Lolk A., Kragh-Sørensen P. Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Archives of Neurology. 2003;60(3):387–392. doi: 10.1001/archneur.60.3.387.
    1. Armento M. E. A., Stanley M. A., Marsh L., et al. Cognitive behavioral therapy for depression and anxiety in Parkinson's disease: a clinical review. Journal of Parkinson's Disease. 2012;2(2):135–151. doi: 10.3233/jpd-2012-12080.
    1. Dobkin R. D., Menza M., Bienfait K. L. CBT for the treatment of depression in Parkinson's disease: a promising nonpharmacological approach. Expert Review of Neurotherapeutics. 2008;8(1):27–35. doi: 10.1586/14737175.8.1.27.
    1. Pachana N. A., Egan S. J., Laidlaw K., et al. Clinical issues in the treatment of anxiety and depression in older adults with Parkinson's disease. Movement Disorders. 2013;28(14):1930–1934. doi: 10.1002/mds.25689.
    1. Pickut B., Vanneste S., Hirsch M. A., et al. Mindfulness training among individuals with Parkinson's disease: neurobehavioral effects. Parkinson's Disease. 2015;2015:6. doi: 10.1155/2015/816404.816404
    1. Kabat-Zinn J. Full Catastrophe Living: Using the Wisdom of your Body and Mind to Face Stress, Pain and Illness. New York, NY, USA: Dell; 1991.
    1. Bishop S. R., Lau M., Shapiro S., et al. Mindfulness: a proposed operational definition. Clinical Psychology: Science and Practice. 2004;11(3):230–241. doi: 10.1093/clipsy/bph077.
    1. Kabat-Zinn J. An outpatient program in behavioral medicine for chronic pain patients based on the practice of mindfulness meditation: theoretical considerations and preliminary results. General Hospital Psychiatry. 1982;4(1):33–47. doi: 10.1016/0163-8343(82)90026-3.
    1. Kabat-Zinn J. Mindfulness-based interventions in context: past, present, and future. Clinical Psychology: Science and Practice. 2003;10(2):144–156. doi: 10.1093/clipsy/bpg016.
    1. Chiesa A., Calati R., Serretti A. Does mindfulness training improve cognitive abilities? A systematic review of neuropsychological findings. Clinical Psychology Review. 2011;31(3):449–464. doi: 10.1016/j.cpr.2010.11.003.
    1. Baer R. A. Mindfulness training as a clinical intervention: a conceptual and empirical review. Clinical Psychology: Science and Practice. 2003;10(2):125–143. doi: 10.1093/clipsy/bpg015.
    1. Baer R. A., Smith G. T., Lykins E., et al. Construct validity of the five facet mindfulness questionnaire in meditating and nonmeditating samples. Assessment. 2008;15(3):329–342. doi: 10.1177/1073191107313003.
    1. Hofmann S. G., Sawyer A. T., Witt A. A., Oh D. The effect of mindfulness-based therapy on anxiety and depression: a meta-analytic review. Journal of Consulting and Clinical Psychology. 2010;78(2):169–183. doi: 10.1037/a0018555.
    1. Menezes C. B., De Paula Couto M. C., Buratto L. G., Erthal F., Pereira M. G., Bizarro L. The improvement of emotion and attention regulation after a 6-week training of focused meditation: a randomized controlled trial. Evidence-Based Complementary and Alternative Medicine. 2013;2013:11. doi: 10.1155/2013/984678.984678
    1. Zeidan F., Johnson S. K., Diamond B. J., David Z., Goolkasian P. Mindfulness meditation improves cognition: evidence of brief mental training. Consciousness and Cognition. 2010;19(2):597–605. doi: 10.1016/j.concog.2010.03.014.
    1. Grossman P., Kappos L., Gensicke H., et al. MS quality of life, depression, and fatigue improve after mindfulness training—a randomized trial. Neurology. 2010;75(13):1141–1149. doi: 10.1212/wnl.0b013e3181f4d80d.
    1. Ott M. J., Norris R. L., Bauer-Wu S. M. Mindfulness meditation for oncology patients: a discussion and critical review. Integrative Cancer Therapies. 2006;5(2):98–108. doi: 10.1177/1534735406288083.
    1. Rosenzweig S., Greeson J. M., Reibel D. K., Green J. S., Jasser S. A., Beasley D. Mindfulness-based stress reduction for chronic pain conditions: variation in treatment outcomes and role of home meditation practice. Journal of Psychosomatic Research. 2010;68(1):29–36. doi: 10.1016/j.jpsychores.2009.03.010.
    1. Fitzpatrick L., Simpson J., Smith A. A qualitative analysis of mindfulness-based cognitive therapy (MBCT) in Parkinson's disease. Psychology and Psychotherapy: Theory, Research and Practice. 2010;83(2):179–192. doi: 10.1348/147608309x471514.
    1. Cash T. V., Ekouevi V. S., Kilbourn C., Lageman S. K. Pilot study of a mindfulness-based group intervention for individuals with Parkinson’s disease and their caregivers. Mindfulness. 2016;7(2):361–371. doi: 10.1007/s12671-015-0452-1.
    1. Hughes A. J., Daniel S. E., Kilford L., Lees A. J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. Journal of Neurology Neurosurgery & Psychiatry. 1992;55(3):181–184. doi: 10.1136/jnnp.55.3.181.
    1. Molloy D. W., Alemayehu E., Roberts R. Reliability of a standardized mini-mental state examination compared with the traditional mini-mental state examination. The American Journal of Psychiatry. 1991;148(1):102–105. doi: 10.1176/ajp.148.1.102.
    1. Baer R. A., Smith G. T., Hopkins J., Krietemeyer J., Toney L. Using self-report assessment methods to explore facets of mindfulness. Assessment. 2006;13(1):27–45. doi: 10.1177/1073191105283504.
    1. Baer R. A., Carmody J., Hunsinger M. Weekly change in mindfulness and perceived stress in a mindfulness-based stress reduction program. Journal of Clinical Psychology. 2012;68(7):755–765. doi: 10.1002/jclp.21865.
    1. Pachana N. A., Byrne G. J., Siddle H., Koloski N., Harley E., Arnold E. Development and validation of the geriatric anxiety inventory. International Psychogeriatrics. 2007;19(1):103–114. doi: 10.1017/s1041610206003504.
    1. Matheson S. F., Byrne G. J., Dissanayaka N. N. W., et al. Validity and reliability of the Geriatric Anxiety Inventory in Parkinson's disease. Australasian Journal on Ageing. 2012;31(1):13–16. doi: 10.1111/j.1741-6612.2010.00487.x.
    1. Dissanayaka N. N. W., Torbey E., Pachana N. A. Anxiety rating scales in Parkinson's disease: a critical review updating recent literature. International Psychogeriatrics. 2015;27(11):1777–1784. doi: 10.1017/s1041610215000885.
    1. Hamilton M. A rating scale for depression. Journal of Neurology, Neurosurgery, and Psychiatry. 1960;23:56–62. doi: 10.1136/jnnp.23.1.56.
    1. Torbey E., Pachana N. A., Dissanayaka N. N. W. Depression rating scales in Parkinson's disease: a critical review updating recent literature. Journal of Affective Disorders. 2015;184:216–224. doi: 10.1016/j.jad.2015.05.059.
    1. Marsh L., McDonald W. M., Cummings J., et al. Provisional diagnostic criteria for depression in Parkinson's disease: report of an NINDS/NIMH Work Group. Movement Disorders. 2006;21(2):148–158. doi: 10.1002/mds.20723.
    1. Pagonabarraga J., Kulisevsky J., Llebaria G., García-Sánchez C., Pascual-Sedano B., Gironell A. Parkinson's disease-cognitive rating scale: a new cognitive scale specific for Parkinson's disease. Movement Disorders. 2008;23(7):998–1005. doi: 10.1002/mds.22007.
    1. Goetz C. G., Tilley B. C., Shaftman S. R., et al. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Movement Disorders. 2008;23(15):2129–2170. doi: 10.1002/mds.22340.
    1. Stebbins G. T., Goetz C. G., Burn D. J., Jankovic J., Khoo T. K., Tilley B. C. How to identify tremor dominant and postural instability/gait difficulty groups with the movement disorder society unified Parkinson's disease rating scale: comparison with the unified Parkinson's disease rating scale. Movement Disorders. 2013;28(5):668–670. doi: 10.1002/mds.25383.
    1. Jenkinson C., Fitzpatrick R., Peto V., Greenhall R., Hyman N. The Parkinson's Disease Questionnaire (PDQ-39): development and validation of a Parkinson's disease summary index score. Age and Aging. 1997;26(5):353–357. doi: 10.1093/ageing/26.5.353.
    1. Lambert M. J., Burlingame G. M., Umphress V., et al. The reliability and validity of the outcome questionnaire. Clinical Psychology and Psychotherapy. 1996;3(4):249–258.
    1. Tomlinson C. L., Stowe R., Patel S., Rick C., Gray R., Clarke C. E. Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Movement Disorders. 2010;25(15):2649–2653. doi: 10.1002/mds.23429.
    1. Harnett P. H., Whittingham K., Puhakka E., Hodges J., Spry C., Dob R. The short-term impact of a brief group-based mindfulness therapy program on depression and life satisfaction. Mindfulness. 2010;1(3):183–188. doi: 10.1007/s12671-010-0024-3.
    1. Dissanayaka N. N. W., Sellbach A., Matheson S., et al. Validity of Hamilton depression inventory in Parkinson's disease. Movement Disorders. 2007;22(3):399–403. doi: 10.1002/mds.21309.
    1. Bauer S., Lambert M. J., Nielsen S. L. Clinical significance methods: a comparison of statistical techniques. Journal of Personality Assessment. 2004;82(1):60–70. doi: 10.1207/s15327752jpa8201_11.
    1. Kabat-Zinn J. Full Catastrophe Living: Using the Wisdom of Your Body and Mind to Face Stress, Pain and Illness. New York, NY, USA: Dell Publishing; 1990.
    1. Dissanayaka N. N. W., White E., O'Sullivan J. D., et al. Characteristics and treatment of anxiety disorders in Parkinson's disease. Movement Disorders Clinical Practice. 2015;2(2):155–162. doi: 10.1002/mdc3.12157.
    1. Dissanayaka N. N. W. Anxiety in Parkinson's disease. In: Byrne G. J., Pachana N. A., editors. Anxiety in Older People: Clinical and Research Perspectives. Cambridge, UK: Cambridge University Press; 2015.
    1. Dissanayaka N. N. W., O'Sullivan J. D., Pachana N. A., et al. Disease-specific anxiety symptomatology in Parkinson's disease. International Psychogeriatrics. 2016 doi: 10.1017/S1041610215002410.
    1. Leentjens A. F. G., Verhey F. R. J., Luijckx G.-J., Troost J. The validity of the Beck depression inventory as a screening and diagnostic instrument for depression in patients with Parkinson's disease. Movement Disorders. 2000;15(6):1221–1224. doi: 10.1002/1531-8257(200011)15:6<1221::AID-MDS1024>;2-H.
    1. Muslimović D., Post B., Speelman J. D., Schmand B. Cognitive profile of patients with newly diagnosed Parkinson disease. Neurology. 2005;65(8):1239–1245. doi: 10.1212/01.wnl.0000180516.69442.95.
    1. Aarsland D., Bronnick K., Williams-Gray C., et al. Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis. Neurology. 2010;75(12):1062–1069. doi: 10.1212/wnl.0b013e3181f39d0e.
    1. Sinforiani E., Banchieri L., Zucchella C., Pacchetti C., Sandrini G. Cognitive rehabilitation in Parkinson's disease. Archives of Gerontology and Geriatrics Supplement. 2004;9:387–391.
    1. París A. P., Saleta H. G., de la Cruz Crespo Maraver M., et al. Blind randomized controlled study of the efficacy of cognitive training in Parkinson's disease. Movement Disorders. 2011;26(7):1251–1258. doi: 10.1002/mds.23688.
    1. Henry J. D., Crawford J. R. Verbal fluency deficits in Parkinson's disease: a meta-analysis. Journal of the International Neuropsychological Society. 2004;10(4):608–622. doi: 10.1017/s1355617704104141.
    1. Williams-Gray C. H., Foltynie T., Brayne C. E. G., Robbins T. W., Barker R. A. Evolution of cognitive dysfunction in an incident Parkinson's disease cohort. Brain. 2007;130(7):1787–1798. doi: 10.1093/brain/awm111.
    1. Litvan I., Goldman J. G., Tröster A. I., et al. Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines. Movement Disorders. 2012;27(3):349–356. doi: 10.1002/mds.24893.
    1. Pickut B. A., Van Hecke W., Kerckhofs E., et al. Mindfulness based intervention in Parkinson's disease leads to structural brain changes on MRI: a randomized controlled longitudinal trial. Clinical Neurology and Neurosurgery. 2013;115(12):2419–2425. doi: 10.1016/j.clineuro.2013.10.002.
    1. Day M. A., Jensen M. P., Ehde D. M., Thorn B. E. Toward a theoretical model for mindfulness-based pain management. The Journal of Pain. 2014;15(7):691–703. doi: 10.1016/j.jpain.2014.03.003.
    1. Sharp K., Hewitt J. Dance as an intervention for people with Parkinson's disease: a systematic review and meta-analysis. Neuroscience and Biobehavioral Reviews. 2014;47:445–456. doi: 10.1016/j.neubiorev.2014.09.009.

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever